S. Revelli et al., ACUTE AND CHRONIC EXPERIMENTAL TRYPANOSOMA-CRUZI INFECTION IN THE RAT- RESPONSE TO SYSTEMIC TREATMENT WITH RECOMBINANT RAT INTERFERON-GAMMA, Microbiology and immunology, 39(4), 1995, pp. 275-281
We examined the effects of recombinant rat inteferon-gamma (IFN-gamma)
injections on the parasitologic, serologic, immunologic and histopath
ologic features of acute and chronic experimental Try-panosoma cruzi (
T. cruzi) infections in ''I'' rats. Upon infection at weaning, two rat
groups were allocated to receive a 20-day cycle of IFN-gamma injectio
ns, 20,000 IU/rat each, which started at 1, and 7 days postinfection (
pi). Treatment with IFN-gamma, initiated at either 1 or 7 days pi, res
ulted in comparatively lower peak parasitemias (P < 0.02) but in simil
ar levels of anti-T. cruzi circulating antibodies and serum IFN-gamma
activities. The latter appeared significantly increased during acute i
nfection whereas biologically active tumor necrosis factor was virtual
ly undetectable in serum from infected rats regardless of whether they
had been given IFN-gamma or not. The prevalence of chronic focal myoc
arditis in IFN-gamma-treated infected rats showed no differences with
respect to the one recorded in control-infected counterparts. The inve
rse CD4/CD8 ratio of spleen and lymph node T cells that usually accomp
anies chronic infection was reversed by IFN-gamma. Mononuclear cells c
arrying class II I-A and I-E molecules, that were found to have increa
sed at both compartments, appeared also modified upon IFN-gamma, treat
ment with an overincrease of I-A-positive cells, and a normalization o
f I-E-bearing cells.